One European Strategy
Creating Value in a Strategic Environment
RECENT MAJOR TRANSACTIONS
Olon Group announces the acquisition of GTP Bioways Group
OES is pleased to have originated a proprietary CDMO Biologics landmark transaction and advised...
Charterhouse partners with Skin Tech Pharma Group
OES is pleased to announce the sale of Skin Tech Pharma of Spain to...
Financial Advisors in M&A: 2022 Awards
Les plus belles progressions du Classement par valeur en 2022, peuvent-elles déjà donner une idée...
GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO by OES
Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global...
Healthcare Webinar organized by Fusions & Acquisitions Magazine
Healthcare Webinar organized by Fusions & Acquisitions Magazine, M&A Review and Intralinks, with precious help...
PharmaZell and Novasep negotiate to create a technology-driven leader for complex small molecules and ADCs.
PharmaZell, the German producer of highly resilient and specialty APIs, and France-based Novasep, a leading...
Sterling Pharma Solutions (UK) acquires Alcami Germantown API Business (USA)
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist...
Business Leadership | by Joseph Carleone
Business Leadership: A requirement for successful M&A outcomes Mergers and acquisitions(M&A)remain a significant driver of...